ArticleCureus2026
Extracorporeal Carbon Dioxide Removal (ECCO₂R) as a Bridge to Extracorporeal Membrane Oxygenation (ECMO) in Severe H1N1-Associated Acute Respiratory Distress Syndrome (ARDS) in Morbid Obesity: A Case From a Resource-Limited Hospital.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the case of a young woman with morbid obesity who developed severe acute respiratory distress syndrome (ARDS) associated with influenza A H1N1 infection, who, despite providing volume-controlled ventilation strategies, with a positive end-expiratory pressure (PEEP) of 12 cmH₂O, tidal volume of 8 mL/kg of predicted body weight and sedation for Richmond Agitation-Sedation Scale (RASS) score of -3, persisted with refractory hypoxemia and permissive hypercapnia off targets. As stabilization therapy, the initiated veno-venous hemodiafiltration continued with ECCO₂R and cycles of at least 24 hours of prone positioning while awaiting referral to extracorporeal membrane oxygenation (ECMO). Influenza virus A subtype H1N1 has single-stranded RNA and displays on its surface two essential glycoproteins, hemagglutinin (cell adhesion) and neuraminidase (release of new virions), that, due to a dysregulated response of cytokines and proinflammatory factors coupled with increased viral replication, induce greater lung injury and risk of progression to severe ARDS. This medical condition continues to be a challenge for health personnel, with special difficulty in patients with conditions such as morbid obesity, where physiological parameters and ventilatory strategies may have significant variations. Given the severity of the cases and the lack of immediate ECMO availability, ECCO₂R may be an alternative for supporting and maintaining protective ventilatory measures, as mentioned in the case below.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.